Trials / Completed
CompletedNCT03052296
BIOLUX P-III SPAIN All-Comers Registry
BIOTRONIK - A Prospective, National, Multi-centre, Post-market Registry to Assess the Clinical Performance of the Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Long Femoropopliteal Artery Lesions - III SPAIN
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- Biotronik AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of the BIOLUX P-III Spain registry is to further investigate the safety and clinical performance of the Passeo-18 Lux Drug Coated Balloon in the treatment of long atherosclerotic femoropoliteal artery lesions in daily clinical practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Passeo-18 Lux DCB | The endovascular procedure is conducted as per the local standard practice and device instruction for use |
Timeline
- Start date
- 2017-03-22
- Primary completion
- 2019-11-05
- Completion
- 2019-11-05
- First posted
- 2017-02-14
- Last updated
- 2021-08-05
Locations
5 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03052296. Inclusion in this directory is not an endorsement.